Regarding RAP2C, previous research has highlighted the potential of this target gene as a therapeutic target in Osteosarcoma, a type of bone cancer occurring mostly in children and adolescents, however the exact role RAP2C plays in bone-related pathways is not discussed [46]. Here, RAP2C is linked to bone cancer.